Miwako Nishio, Minori Saito, Mayumi Yoshimori, Yuki Kumaki, Ayaka Ohashi, Eri Susaki, Ichiro Yonese, Megumi Sawada, Ayako Arai. Clinical significance of anti-Epstein-Barr virus antibodies in systemic chronic active Epstein-Barr virus disease. Frontiers in Microbiology. 2024. 14
Yu Uemura, Ayaka Ohashi, Mayumi Yoshimori, Miwako Nishio, Tsuneaki Hirakawa, Norio Shimizu, Naomi Wada, Ken-Ichi Imadome, Ayako Arai. Plasma interferon-γ concentration: a potential biomarker of disease activity of systemic chronic active Epstein-Barr virus infection. Frontiers in Virology. 2022. 2
Ayaka Ohashi, Yu Uemura, Mayumi Yoshimori, Naomi Wada, Ken-Ichi Imadome, Kazuo Yudo, Takatoshi Koyama, Norio Shimizu, Miwako Nishio, Ayako Arai. The Plasma Level of Interleukin-1β Can Be a Biomarker of Angiopathy in Systemic Chronic Active Epstein-Barr Virus Infection. Frontiers in Microbiology. 2022. 13
Mayumi Yoshimori, Miwako Nishio, Ayaka Ohashi, Megumi Tateishi, Ayaka Mimura, Naomi Wada, Minori Saito, Norio Shimizu, Ken-Ichi Imadome, Ayako Arai. Interferon-γ Produced by EBV-Positive Neoplastic NK-Cells Induces Differentiation into Macrophages and Procoagulant Activity of Monocytes, Which Leads to HLH. Cancers. 2021. 13. 20. 5097-5097
Mayumi Yoshimori, Haruna Shibayama, Ken-Ichi Imadome, Fuyuko Kawano, Ayaka Ohashi, Miwako Nishio, Norio Shimizu, Morito Kurata, Shigeyoshi Fujiwara, Ayako Arai. Antineoplastic and anti-inflammatory effects of bortezomib on systemic chronic active EBV infection. Blood advances. 2021. 5. 7. 1805-1815
西尾 美和子, 中原 正子, 湯尾 明, 佐伯 久美子. ヒト多能性幹細胞(ES/iPS細胞)からの褐色脂肪細胞の作製 (第73回関東・甲信越支部例会 シンポジウム 保健(医療技術)学部における臨床検査医学研究). 臨床病理 = The official journal of Japanese Society of Laboratory Medicine : 日本臨床検査医学会誌. 2017. 65. 10. 1134-1139
